Universitätsklinikum Hamburg-Eppendorf (UKE)

A multicenter, randomized, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (mBC) (DESIREE) (2021) Loibl S, Schmidt M, Luebbe K, Decker T, Thill M, Bauer L, Mueller V, et al. Conference contribution Clinico-genetic findings in 509 frontotemporal dementia patients (2021) Wagner M, Lorenz G, Volk AE, Brunet T, Edbauer D, Berutti R, Zhao C, et al. Journal article Congenital disorders of glycosylation with defective fucosylation (2021) Huellen A, Falkenstein K, Weigel C, Huidekoper H, Naumann-Bartsch N, Spenger J, Feichtinger RG, et al. Journal article Activation of the trigeminal system as a likely target of SARS-CoV-2 may contribute to anosmia in COVID-19 (2021) Meßlinger K, Neuhuber W, May A Journal article Behandlung der Psoriasis mit Secukinumab: Praxisrelevante Hinweise (2021) Körber A, Augustin M, Behrens F, Gerdes S, von Kiedrowski R, Schäkel K, Sticherling M, et al. Journal article, Review article S2k guideline: Diagnosis and management of cutaneous lupus erythematosus – Part 2: Therapy, risk factors and other special topics (2021) Worm M, Zidane M, Eisert L, Fischer-Betz R, Foeldvari I, Gunther C, Iking-Konert C, et al. Journal article The rate of cholangiocarcinoma in Caroli Disease A German multicenter study (2021) Fard-Aghaie MH, Makridis G, Reese T, Feyerabend B, Wagner KC, Schnitzbauer A, Bechstein WO, et al. Journal article Prognostic value of cta-derived left ventricular mass in neonates with congenital heart disease (2021) Ellmann S, Nickel JM, Heiß R, El Amrani N, Wüst W, Rompel O, Rueffer A, et al. Journal article Frühes Mammakarzinom: Aktuelle Strategien in der System- und Radiotherapie: 17. Internationale St.-Gallen-Konsensuskonferenz vor dem Hintergrund deutscher Therapieempfehlungen diskutiert (2021) Schneeweiss A, Huober J, Brucker SY, Budach W, Denkert C, Fasching P, Haidinger R, et al. Journal article Prognosis of Patients with Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment: A Phase 3 Randomized Clinical Trial (2021) Friedl TWP, Fehm T, Mueller V, Lichtenegger W, Blohmer J, Lorenz R, Forstbauer H, et al. Journal article